Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

826.07 +15.64 (+1.93%)
Official Closing Price Updated: 7:00 PM EST, Feb 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,299,752
Open 811.05
Bid (Size) 824.02 (1)
Ask (Size) 825.50 (4)
Prev. Close 810.43
Today's Range 805.93 - 829.04
52wk Range 682.53 - 972.53
Shares Outstanding N/A
Dividend Yield 0.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk Faces Investor Concerns Over Hybrid CagriSema Trial Results For Weight Loss
Novo Nordisk's CagriSema trial raised concerns as patients reported weight loss but significant side effects. Investors question trial protocols and transparency as Novo plans a new study. 
Via Benzinga
3 Magnificent Stocks to Buy and Hold Forever
Via The Motley Fool

Performance

YTD
+6.17%
+6.17%
1 Month
+7.97%
+7.97%
3 Month
+2.48%
+2.48%
6 Month
+4.15%
+4.15%
1 Year
+16.97%
+16.97%

More News

Read More
Market Briefing For Monday, Feb. 3, 2025
Via Talk Markets
Topics Commodities Stocks / Equities World Trade
Exposures Tariff
With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?
Via The Motley Fool
Got $1,000? 2 Top Growth Stocks to Buy Right Now
Via The Motley Fool
Eli Lilly Unusual Options Activity
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Market Whales and Their Recent Bets on LLY Options
Via Benzinga
Assessing Eli Lilly: Insights From 7 Financial Analysts
Via Benzinga
3 Unstoppable Stocks You Can Buy and Hold for the Rest of Your Life
Via The Motley Fool
MarketBeat Week in Review – 01/27 - 01/31
Via MarketBeat
Topics Economy
Exposures Interest Rates
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Via Benzinga
5 Top Stocks to Buy in February 2025
Via The Motley Fool
Billionaire Philippe Laffont Just Sold Top Artificial Intelligence Stocks Nvidia and AMD and Piled Into 2 Players Dominating Another High-Growth Billion-Dollar Industry
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
How We Can Trade On GDP
Via Talk Markets
Topics Commodities Futures Stocks / Equities
RFK Jr. And Big Pharma: Health Secretary Hopeful Answers Pointed Questions On Drugs, Insurance, Trump Exec Orders
Via Benzinga
Topics Government
Exposures Political
Jim Cramer: This Industrial Stock Is 'Absolutely Terrific', First Solar Is 'Very Inexpensive'
Via Benzinga
Marjorie Taylor Greene Loads Up On Meta, Amazon, Tesla, Nvidia And Other Stocks As Donald Trump's New Equations With Big Tech Leaders Sets Stage For Growth: What Is At Stake?
Via Benzinga
Topics Government
Exposures Political
What Does the Future Hold for Eli Lilly?
Via MarketBeat
AI Pharma: 2 Paths to AI-Powered Drug Investment
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Biotech And Healthcare Stocks Poised For Gains Ahead
Via Talk Markets
Topics ETFs Stocks / Equities
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
Via The Motley Fool
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Via The Motley Fool
Prediction: 3 Stocks That'll Be Worth More Than Berkshire Hathaway 5 Years From Now
Via The Motley Fool
Why Eli Lilly Stock Topped the Market Today
Via The Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.